AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 26-50/142
DIFFERENTIAL CD95 EXPRESSION AND FUNCTION IN T-LINEAGE AND B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS
Authors: KARAWAJEW L WUCHTER C RUPPERT V DREXLER H GRUSS HJ DORKEN B LUDWIG WD
Citation: L. Karawajew et al., DIFFERENTIAL CD95 EXPRESSION AND FUNCTION IN T-LINEAGE AND B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS, Leukemia, 11(8), 1997, pp. 1245-1252
ROLE OF CRANIAL RADIOTHERAPY FOR CHILDHOOD T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA WITH HIGH WBC COUNT AND GOOD RESPONSE TO PREDNISONE
Authors: CONTER V SCHRAPPE M ARICO M REITER A RIZZARI C DORDELMANN M VALSECCHI MG ZIMMERMANN M LUDWIG WD BASSO G MASERA G
Citation: V. Conter et al., ROLE OF CRANIAL RADIOTHERAPY FOR CHILDHOOD T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA WITH HIGH WBC COUNT AND GOOD RESPONSE TO PREDNISONE, Journal of clinical oncology, 15(8), 1997, pp. 2786-2791
EXPRESSION OF THE STEM-CELL FACTOR-RECEPTOR C-KIT (CD117) IN ACUTE LEUKEMIAS
Authors: SPERLING C SCHWARTZ S BUCHNER T THIEL E LUDWIG WD
Citation: C. Sperling et al., EXPRESSION OF THE STEM-CELL FACTOR-RECEPTOR C-KIT (CD117) IN ACUTE LEUKEMIAS, Haematologica, 82(5), 1997, pp. 617-621
HEMATOPOIETIC GROWTH-FACTORS IN ACUTE MYELOID-LEUKEMIA - SUPPORTIVE AND PRIMING EFFECTS
Authors: BUCHNER T HIDDEMANN W WORMANN B ZUHLSDORF M ROTTMANN R INNIG G MASCHMEIER G LUDWIG WD SAUERLAND MC HEINECKE A
Citation: T. Buchner et al., HEMATOPOIETIC GROWTH-FACTORS IN ACUTE MYELOID-LEUKEMIA - SUPPORTIVE AND PRIMING EFFECTS, Seminars in oncology, 24(1), 1997, pp. 124-131
NEW INSIGHTS INTO THE BIOLOGY OF PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA USING A COMBINATION OF MAY-GRUNWALD-GIEMSA STAINING AND FLUORESCENCE IN-SITU HYBRIDIZATION TECHNIQUES AT THE SINGLE-CELL LEVEL
Authors: HAFERLACH T WINKEMANN M RAMMPETERSEN L MEEDER M SCHOCH R WEBERMATTHIESEN K SCHLEGELBERGER B SCHOCH C LUDWIG WD HIDDEMANN W LOFFLER H
Citation: T. Haferlach et al., NEW INSIGHTS INTO THE BIOLOGY OF PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA USING A COMBINATION OF MAY-GRUNWALD-GIEMSA STAINING AND FLUORESCENCE IN-SITU HYBRIDIZATION TECHNIQUES AT THE SINGLE-CELL LEVEL, British Journal of Haematology, 99(2), 1997, pp. 452-459
MORPHOLOGICAL AND CYTOCHEMICAL FINDINGS IN 150 CASES OF T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
Authors: GASSMANN W LOFFLER H THIEL E LUDWIG WD SCHWARTZ S HAFERLACH T MAURER J RIEDER H FONATSCH C GOKBUGET N HOELZER D
Citation: W. Gassmann et al., MORPHOLOGICAL AND CYTOCHEMICAL FINDINGS IN 150 CASES OF T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS, British Journal of Haematology, 97(2), 1997, pp. 372-382
EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN CHILDHOODACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATION WITH CLINICAL-FEATURES ANDOUTCOME
Authors: MIELCAREK M SPERLING C SCHRAPPE M MEYER U RIEHM H LUDWIG WD
Citation: M. Mielcarek et al., EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN CHILDHOODACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATION WITH CLINICAL-FEATURES ANDOUTCOME, British Journal of Haematology, 96(2), 1997, pp. 301-307
INCIDENCE AND CLINICAL RELEVANCE OF TEL AML1 FUSION GENES IN CHILDRENWITH ACUTE LYMPHOBLASTIC-LEUKEMIA ENROLLED IN THE GERMAN AND ITALIAN MULTICENTER THERAPY TRIALS/
Authors: BORKHARDT A CAZZANIGA G VIEHMANN S VALSECCHI MG LUDWIG WD BURCI L MANGIONI S SCHRAPPE M RIEHM H LAMPERT F BASSO G MASERA G HARBOTT J BIONDI A
Citation: A. Borkhardt et al., INCIDENCE AND CLINICAL RELEVANCE OF TEL AML1 FUSION GENES IN CHILDRENWITH ACUTE LYMPHOBLASTIC-LEUKEMIA ENROLLED IN THE GERMAN AND ITALIAN MULTICENTER THERAPY TRIALS/, Blood, 90(2), 1997, pp. 571-577
SIGNIFICANT ASSOCIATION OF ABERRANT CD13 COEXPRESSION WITH TEL-AML-1 POSITIVE CHILDHOOD C-ALL
Authors: GRIESINGER F RENZIEHAUSEN A SCHNITTGER S RITTER J LUDWIG WD HIDDEMANN W WORMANN B
Citation: F. Griesinger et al., SIGNIFICANT ASSOCIATION OF ABERRANT CD13 COEXPRESSION WITH TEL-AML-1 POSITIVE CHILDHOOD C-ALL, Blood, 90(10), 1997, pp. 3592-3592
CD95 (APO-1 FAS) MUTATIONS IN CHILDHOOD ACUTE LYMPHOBLASTIC T-CELL LEUKEMIA/
Authors: BELTINGER C KURZ E BOHLER T SCHRAPPE M LUDWIG WD DEBATIN KM
Citation: C. Beltinger et al., CD95 (APO-1 FAS) MUTATIONS IN CHILDHOOD ACUTE LYMPHOBLASTIC T-CELL LEUKEMIA/, Blood, 90(10), 1997, pp. 3619-3619
PROGNOSIS OF ELDERLY AML PATIENTS EXCLUDED FROM A RANDOMIZED MULTICENTER TRIAL
Authors: WORMANN B SAUERLAND C HEINECKE A LOFFLER H GASSMANN W HAFERLACH T HOSSFELD D LENGFELDER E LUDWIG WD MASCHMEYER G GRUNEISEN A EIMERMACHER H SCHADECKGRESSEL C HIDDEMANN W BUCHNER T
Citation: B. Wormann et al., PROGNOSIS OF ELDERLY AML PATIENTS EXCLUDED FROM A RANDOMIZED MULTICENTER TRIAL, Blood, 90(10), 1997, pp. 3860-3860
BENEFIT OF INTENSIFIED CONSOLIDATION THERAPY WITH AND WITHOUT ALLOGENEIC BMT FOR SUBSETS OF HIGH-RISK ALL IN TRIAL ALL-BFM-90
Authors: REITER A EBELL W SCHRAPPE M HARBOTT J LUDWIG WD KLINGEBIEL T ZINTL F HENZE G GADNER H WELTE K RIEHM H
Citation: A. Reiter et al., BENEFIT OF INTENSIFIED CONSOLIDATION THERAPY WITH AND WITHOUT ALLOGENEIC BMT FOR SUBSETS OF HIGH-RISK ALL IN TRIAL ALL-BFM-90, Blood, 90(10), 1997, pp. 997-997
MLL AND CALM ARE FUSED TO AF10 IN MORPHOLOGICALLY DIFFERENT SUBSETS OF ACUTE-LEUKEMIA WITH TRANSLOCATION T(10-11) - BOTH REARRANGEMENTS AREASSOCIATED WITH POOR-PROGNOSIS
Authors: DREYLING MH SCHRADER C FONATSCH C SCHLEGELBERGER B HAASE D SCHOCH C LUDWIG WD BUCHNER T WORMANN B HIDDEMANN W BOHLANDER SK
Citation: Mh. Dreyling et al., MLL AND CALM ARE FUSED TO AF10 IN MORPHOLOGICALLY DIFFERENT SUBSETS OF ACUTE-LEUKEMIA WITH TRANSLOCATION T(10-11) - BOTH REARRANGEMENTS AREASSOCIATED WITH POOR-PROGNOSIS, Blood, 90(10), 1997, pp. 1417-1417
THE RELIABILITY AND SPECIFICITY OF C-KIT FOR THE DIAGNOSIS OF ACUTE MYELOID LEUKEMIAS AND UNDIFFERENTIATED LEUKEMIAS - EUROPEAN GROUP FOR THE IMMUNOLOGICAL CLASSIFICATION OF LEUKEMIAS (EGIL)
Authors: BENE MC BERNIER M CASTOLDI G KNAPP W LUDWIG WD MATUTES E ORFAO A VANTVEER MB
Citation: Mc. Bene et al., THE RELIABILITY AND SPECIFICITY OF C-KIT FOR THE DIAGNOSIS OF ACUTE MYELOID LEUKEMIAS AND UNDIFFERENTIATED LEUKEMIAS - EUROPEAN GROUP FOR THE IMMUNOLOGICAL CLASSIFICATION OF LEUKEMIAS (EGIL), Blood, 90(10), 1997, pp. 2226-2226
LATE EVENTS IN AML - DATA FROM LONG-TERM OBSERVATION OF PATIENTS IN 2TRIALS STARTING IN 1981 AND 1985
Authors: BUCHNER T HIDDEMANN W WORMANN B LOFFLER H GASSMANN W HAFERLACH T FONATSCH C HOSSFELD D MASCHMEYER G LENGFELDER E AUL C HEYLL A LUDWIG WD SAUERLAND MC HEINECKE A
Citation: T. Buchner et al., LATE EVENTS IN AML - DATA FROM LONG-TERM OBSERVATION OF PATIENTS IN 2TRIALS STARTING IN 1981 AND 1985, Blood, 90(10), 1997, pp. 2247-2247
THERAPEUTIC OUTCOME IN AML IS MAINLY DETERMINED BY CYTOGENETICS, LDH IN SERUM, EARLY RESPONSE AND, IN A POOR-RISK SUBGROUP, BY INTENSIFIED INDUCTION TREATMENT
Authors: BUCHNER T HIDDEMANN W WORMANN B LOFFLER H GASSMANN W HAFERLACH T FONATSCH C HOSSFELD D MASCHMEYER G LENGFELDER E AUL C HEYLL A LUDWIG WD SAUERLAND MC HEINECKE A
Citation: T. Buchner et al., THERAPEUTIC OUTCOME IN AML IS MAINLY DETERMINED BY CYTOGENETICS, LDH IN SERUM, EARLY RESPONSE AND, IN A POOR-RISK SUBGROUP, BY INTENSIFIED INDUCTION TREATMENT, Blood, 90(10), 1997, pp. 2248-2248
CAPABILITY OF IL-7 TO PREVENT IN-VITRO SPONTANEOUS APOPTOSIS OF T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) CELLS CORRELATES WITH A CORTICAL MATURE PHENOTYPE AND A GOOD INITIAL IN-VIVO RESPONSE TO CHEMOTHERAPY/
Authors: KARAWAJEW L KOSSER A RUPPERT V MARTIN M SCHRAPPE M DORKEN B LUDWIG WD
Citation: L. Karawajew et al., CAPABILITY OF IL-7 TO PREVENT IN-VITRO SPONTANEOUS APOPTOSIS OF T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) CELLS CORRELATES WITH A CORTICAL MATURE PHENOTYPE AND A GOOD INITIAL IN-VIVO RESPONSE TO CHEMOTHERAPY/, Blood, 90(10), 1997, pp. 2493-2493
DAUNORUBICIN 60 INSTEAD OF 30 MG SQM IMPROVES RESPONSE AND SURVIVAL IN ELDERLY PATIENTS WITH AML/
Authors: BUCHNER T HIDDEMANN W WORMANN B LOFFLER H GASSMANN W HAFERLACH T FONATSCH C HOSSFELD D LENGFELDER E LUDWIG WD MASCHMEYER G SAUERLAND MC HEINECKE A
Citation: T. Buchner et al., DAUNORUBICIN 60 INSTEAD OF 30 MG SQM IMPROVES RESPONSE AND SURVIVAL IN ELDERLY PATIENTS WITH AML/, Blood, 90(10), 1997, pp. 2596-2596
ACUTE MYELOID-LEUKEMIA WITH TRANSLOCATION (8-21) - CYTOMORPHOLOGY, DYSPLASIA AND PROGNOSTIC FACTORS IN 41 CASES
Authors: HAFERLACH T BENNETT JM LOFFLER H GASSMANN W ANDERSEN JW TUZUNER N CASSLLETH PA FONATSCH C SCHOCH C SCHLEGELBERGER B BECHER R THIEL E LUDWIG WD SAUERLAND MC HEINECKE A BUCHNER T
Citation: T. Haferlach et al., ACUTE MYELOID-LEUKEMIA WITH TRANSLOCATION (8-21) - CYTOMORPHOLOGY, DYSPLASIA AND PROGNOSTIC FACTORS IN 41 CASES, Leukemia & lymphoma, 23(3-4), 1996, pp. 227-234
CLASSIFICATION OF ACUTE LEUKEMIAS - REPLY
Authors: BENE MC CASTOLDI G KNAPP W LUDWIG WD MATUTES E ORFAO A VANTVEER MB
Citation: Mc. Bene et al., CLASSIFICATION OF ACUTE LEUKEMIAS - REPLY, Leukemia, 10(8), 1996, pp. 1363-1364
INCIDENCE AND CLINICAL OUTCOME OF CHILDREN WITH BCR ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PROSPECTIVE RT-PCR STUDY BASED ON 673 PATIENTS ENROLLED IN THE GERMAN PEDIATRIC MULTICENTER THERAPY TRIALS ALL-BFM-90 AND COALL-05-92/
Authors: SCHLIEBEN S BORKHARDT A REINISCH I RITTERBACH J JANSSEN JWG RATEI R SCHRAPPE M REPP R ZIMMERMANN M KABISCH H JANKASCHAUB G BARTRAM CR LUDWIG WD RIEHM H LAMPERT F HARBOTT J
Citation: S. Schlieben et al., INCIDENCE AND CLINICAL OUTCOME OF CHILDREN WITH BCR ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PROSPECTIVE RT-PCR STUDY BASED ON 673 PATIENTS ENROLLED IN THE GERMAN PEDIATRIC MULTICENTER THERAPY TRIALS ALL-BFM-90 AND COALL-05-92/, Leukemia, 10(6), 1996, pp. 957-963
CONSENSUS PROTOCOL FOR THE FLOW CYTOMETRIC IMMUNOPHENOTYPING OF HEMATOPOIETIC MALIGNANCIES
Authors: ROTHE G SCHMITZ G ADORF D BARLAGE S GRAMATZKI M HANENBERG H HOFFKES HG JANOSSY G KNUCHEL R LUDWIG WD NEBE T NERL C ORFAO A SERKE S SONNEN R TICHELLI A WORMANN B
Citation: G. Rothe et al., CONSENSUS PROTOCOL FOR THE FLOW CYTOMETRIC IMMUNOPHENOTYPING OF HEMATOPOIETIC MALIGNANCIES, Leukemia, 10(5), 1996, pp. 877-895
EFFECTS OF FLT3 LIGAND ON HUMAN LEUKEMIA-CELLS .1. PROLIFERATIVE RESPONSE OF MYELOID-LEUKEMIA CELLS
Authors: DEHMEL U ZABORSKI M MEIERHOFF G ROSNET O BIRNBAUM D LUDWIG WD QUENTMEIER H DREXLER HG
Citation: U. Dehmel et al., EFFECTS OF FLT3 LIGAND ON HUMAN LEUKEMIA-CELLS .1. PROLIFERATIVE RESPONSE OF MYELOID-LEUKEMIA CELLS, Leukemia, 10(2), 1996, pp. 261-270
EXPRESSION OF THE RECEPTOR MPL AND PROLIFERATIVE EFFECTS OF ITS LIGAND THROMBOPOIETIN ON HUMAN LEUKEMIA-CELLS
Authors: QUENTMEIER H ZABORSKI M GRAF G LUDWIG WD DREXLER HG
Citation: H. Quentmeier et al., EXPRESSION OF THE RECEPTOR MPL AND PROLIFERATIVE EFFECTS OF ITS LIGAND THROMBOPOIETIN ON HUMAN LEUKEMIA-CELLS, Leukemia, 10(2), 1996, pp. 297-310
MYELODYSPLASIA AND ACUTE MYELOGENOUS LEUKEMIA IN DOWNS-SYNDROME - A REPORT OF 40 CHILDREN OF THE AML-BFM STUDY-GROUP
Authors: CREUTZIG U RITTER J VORMOOR J LUDWIG WD NIEMEYER C REINISCH I STOLLMANNGIBBELS B ZIMMERMANN M HARBOTT J
Citation: U. Creutzig et al., MYELODYSPLASIA AND ACUTE MYELOGENOUS LEUKEMIA IN DOWNS-SYNDROME - A REPORT OF 40 CHILDREN OF THE AML-BFM STUDY-GROUP, Leukemia, 10(11), 1996, pp. 1677-1686
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>